James R. Falsey - Concepedia

Concepedia

Author

James R. Falsey

Amgen (United States)

Also Known As

J. R. Falsey, James Falsey, James R. Falsey

16

Publications

1.1K

Citations

12

H-Index

20

Concepts

All Affiliations

Amgen (United States)

JR

About

James R. Falsey is an author at Amgen (United States) specializing in drug development, drug discovery, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	100
2	Natural Sciences	2	2	63
3	Biochemistry	2	2	63
4	Engineering	1	1	78
5	Chemical Biology	1	1	37

James R. Falsey

×

12

Publications

1.1K

Citations

12

H-Index

	Year	Citations
Peptide and Small Molecule Microarray for High Throughput Cell Adhesion and Functional Assays James R. Falsey, Manat Renil, Steven Park, Bioconjugate Chemistry	2001	324
A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings Murielle M. Véniant, Shu-Chen Lu, Larissa Atangan, Nature Metabolism	2024	160
Chronic glucose-dependent insulinotropic polypeptide receptor (GIPR) agonism desensitizes adipocyte GIPR activity mimicking functional GIPR antagonism Elizabeth A. Killion, Michelle Chen, James R. Falsey, Nature Communications	2020	129
Novel Vanilloid Receptor-1 Antagonists: 2. Structure−Activity Relationships of 4-Oxopyrimidines Leading to the Selection of a Clinical Candidate Elizabeth M. Doherty, Christopher Fotsch, Anthony W. Bannon, Journal of Medicinal Chemistry	2007	98
GIPR antagonist antibodies conjugated to GLP-1 peptide are bispecific molecules that decrease weight in obese mice and monkeys Shu-Chen Lu, Michelle Chen, Larissa Atangan, Cell Reports Medicine	2021	80
Palladium-Catalyzed Chemoselective Monoarylation of Hydrazides for the Synthesis of [1,2,4]Triazolo[4,3-<i>a</i>]pyridines Andreas Reichelt, James R. Falsey, Robert M. Rzasa, Organic Letters Chemical EngineeringEngineeringOrganic ChemistryMicrowave IrradiationCatalysis	2010	78
Discovery of Highly Selective and Potent p38 Inhibitors Based on a Phthalazine Scaffold Brad Herberich, Guoqiang Cao, Partha Chakrabarti, Journal of Medicinal Chemistry	2008	57
N-substituted azaindoles as potent inhibitors of Cdc7 kinase Marian C. Bryan, James R. Falsey, Mike Frohn, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicineCdc7 KinaseAnti-cancer AgentDrug Development	2013	37
Rapid Development of Piperidine Carboxamides as Potent and Selective Anaplastic Lymphoma Kinase Inhibitors Marian C. Bryan, Douglas A. Whittington, Elizabeth M. Doherty, Journal of Medicinal Chemistry Drug TargetPiperidine CarboxamidesPeptide SciencePharmacotherapyChemical Biology	2012	37
Engineering Antibody Reactivity for Efficient Derivatization to Generate Na<sub>V</sub>1.7 Inhibitory GpTx-1 Peptide–Antibody Conjugates Kaustav Biswas, Thomas Nixey, Justin K. Murray, ACS Chemical Biology	2017	28

Page 1